ibuprofen + chlorpheniramine + phenylephrine

**Irlanda-2-Association** is a fixed-dose oral combination product containing **ibuprofen**, **chlorpheniramine**, and **phenylephrine**, developed by **EMS** for symptomatic treatment of the **common cold**. Based on the provided clinical trial record, the name appears to be a study-specific or product-specific label for this three-drug combination rather than a distinct new molecular entity. The combination pairs a nonsteroidal anti-inflammatory drug for pain, fever, and inflammatory symptoms, an H1 antihistamine for rhinorrhea and sneezing, and an alpha-1 adrenergic agonist decongestant for nasal congestion. It is therefore best characterized as a multi-ingredient symptomatic cold medication rather than a novel single-agent therapeutic.

Brand names

Irlanda-2Irlanda2Irlanda 2

Other names

Irlanda-2-AssociationIrlanda2-AssociationIrlanda 2-Associationibuprofen + chlorpheniramine + phenylephrine